NIH Public/Private Partnerships And Health Care Reform High On Director Collins' Agenda
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry collaborations are crucial in bringing the "discoveries that are bursting around us" to bear on development of diagnostics, preventive strategies and therapeutics, Collins says; NIH will brainstorm with economists on the cost-effectiveness of medical research.
You may also be interested in...
Stable NIH Funding Is Pressed By Industry/Academia Advocacy Group
United for Medical Research, a year-old advocacy organization that boasts BIO as a founding member, is bringing academic and industry groups together in a long-range effort to end the boom or bust funding cycles experienced by the National Institutes of Health
Stable NIH Funding Is Pressed By Industry/Academia Advocacy Group
United for Medical Research, a year-old advocacy organization that boasts BIO as a founding member, is bringing academic and industry groups together in a long-range effort to end the boom or bust funding cycles experienced by the National Institutes of Health
AHRQ To Put More Than Half Of Stimulus CER Funding To Evidence Generation
The Agency for Healthcare Research and Quality is planning to spend $173 million, of the $300 million allocated to it for comparative effectiveness research by the American Recovery and Reinvestment Act, on evidence generation